4.5 Article

Middle East respiratory syndrome coronavirus (MERS-CoV) neutralising antibodies in a high-risk human population, Morocco, November 2017 to January 2018

Journal

EUROSURVEILLANCE
Volume 24, Issue 48, Pages 43-50

Publisher

EUR CENTRE DIS PREVENTION & CONTROL
DOI: 10.2807/1560-7917.ES.2019.24.48.1900244

Keywords

-

Funding

  1. WHO-Regional Office for Eastern Mediterranean
  2. National Institute of Allergy and Infectious Disease, National Institutes of Health [HHSN272201400006C]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available